These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7802310)

  • 41. Managing Opioid Withdrawal in the Emergency Department With Buprenorphine.
    Herring AA; Perrone J; Nelson LS
    Ann Emerg Med; 2019 May; 73(5):481-487. PubMed ID: 30616926
    [No Abstract]   [Full Text] [Related]  

  • 42. Buprenorphine: a newer drug for treating neonatal abstinence syndrome.
    Bell SG
    Neonatal Netw; 2012; 31(3):178-83. PubMed ID: 22564314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Postoperative pain relief with various epidural narcotics: demerol, butorphanol, nalbuphine, and morphine].
    Wang JJ; Shwei SP; Can KH; Lee TY; Chan TH; Liu SE; Mok MS
    Ma Zui Xue Za Zhi; 1988 Mar; 26(1):15-24. PubMed ID: 3043133
    [No Abstract]   [Full Text] [Related]  

  • 44. Detoxification and treating opioid dependence.
    Contreras JA
    JAMA; 2006 Feb; 295(8):886-7; author reply 887-8. PubMed ID: 16493097
    [No Abstract]   [Full Text] [Related]  

  • 45. Canadian developments. Buprenorphine now approved for the treatment of opiate addiction.
    Garmaise D
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):20, 22. PubMed ID: 16365961
    [No Abstract]   [Full Text] [Related]  

  • 46. Educating Nurses on the Use of the Clinical Opiate Withdrawal Scale to Improve Care of Adult Patients Undergoing Buprenorphine Induction.
    J Addict Nurs; 2020; 31(4):E38-E39. PubMed ID: 33264209
    [No Abstract]   [Full Text] [Related]  

  • 47. Gradual dose taper following chronic buprenorphine.
    Becker AB; Strain EC; Bigelow GE; Stitzer ML; Johnson RE
    Am J Addict; 2001; 10(2):111-21. PubMed ID: 11444154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prescribing of buprenorphine by advanced practice addictions nurses.
    Strobbe S; Hobbins D
    J Addict Nurs; 2012 Feb; 23(1):82-3. PubMed ID: 22468667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Office-based treatment of opioid-dependent patients.
    Ferner RE; Daniels AM
    N Engl J Med; 2003 Jan; 348(1):81-2; author reply 81-2. PubMed ID: 12510051
    [No Abstract]   [Full Text] [Related]  

  • 50. The emperor' s new clothes.
    Schnoll SH
    J Addict Dis; 2003; 22(4):1-4. PubMed ID: 14723473
    [No Abstract]   [Full Text] [Related]  

  • 51. [New developments and findings in the field of opiates, opioids, opiate receptors and complete and partial opiate antagonists].
    Schneider M; Bunge HJ; Heinrich F
    Anaesthesiol Reanim; 1990; 15(3):138-44. PubMed ID: 2168183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine.
    White R; Alcorn R; Feinmann C
    Drug Alcohol Depend; 2001 Dec; 65(1):77-83. PubMed ID: 11714592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Buprenorphine-naloxone.
    Hu T; Nijmeh L; Pyle A
    CMAJ; 2018 Nov; 190(47):E1389. PubMed ID: 30478217
    [No Abstract]   [Full Text] [Related]  

  • 54. Buprenorphine prescribing by APRNs.
    Rundio A
    J Addict Nurs; 2012 Feb; 23(1):80-1. PubMed ID: 22468666
    [No Abstract]   [Full Text] [Related]  

  • 55. Injection Butorphanol dependence: A case report.
    Shah B; Gupta R; Sarkar S; Balhara YPS
    Asian J Psychiatr; 2018 Jun; 35():45-46. PubMed ID: 29778749
    [No Abstract]   [Full Text] [Related]  

  • 56. Buprenorphine diffusion: the attitudes of substance abuse treatment counselors.
    Knudsen HK; Ducharme LJ; Roman PM; Link T
    J Subst Abuse Treat; 2005 Sep; 29(2):95-106. PubMed ID: 16135338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clonidine in opiate withdrawal. II. Potential side-effects].
    Keup W
    MMW Munch Med Wochenschr; 1982 Feb; 124(7):153-5. PubMed ID: 6801495
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clonidine in opiate withdrawal. III. Pros and cons of administration].
    Keup W
    MMW Munch Med Wochenschr; 1982 Feb; 124(7):156-8. PubMed ID: 6801496
    [No Abstract]   [Full Text] [Related]  

  • 59. [Progress in the treatment of opiate dependence].
    Wu LZ; Cui CL; Han JS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Sep; 15(9):569-73. PubMed ID: 8704444
    [No Abstract]   [Full Text] [Related]  

  • 60. [NMDA-receptor antagonists: new pharmacological agents to control the subjective and motivational effects of narcotics].
    Bespalov AIu; Zvartau EE
    Vestn Ross Akad Med Nauk; 1998; (11):24-9. PubMed ID: 9889701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.